Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
BOCX On Other Exchanges
As of 8:10 PM 09/3/14 All times are local (Market data is delayed by at least 15 minutes).

biocurex inc (BOCX) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/24/14 - $0.14
52 Week Low
11/7/13 - $0.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOCUREX INC (BOCX)

Related News

No related news articles were found.

biocurex inc (BOCX) Related Businessweek News

No Related Businessweek News Found

biocurex inc (BOCX) Details

BioCurex, Inc., a development stage company, engages in developing, producing, marketing, and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It develops various product candidates based on RECAF technology. The company offers its RECAF technology in three basic formats, including automated testing in large clinical and hospital laboratories; non-automated or manual testing by clinicians in smaller laboratory settings; and point-of-care rapid test formats for physicians’ offices, and urgent care facilities. It also develops RECAF marker, a cancer marker, which is used in blood tests to detect the presence of cancer in humans and animals. The company was formerly known as Whispering Oaks International, Inc. and changed its name to Biocurex, Inc. in October 2009. Biocurex, Inc. was incorporated in 1997 and is based in Richmond, Canada.

biocurex inc (BOCX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biocurex inc (BOCX) Key Developments

SEC Orders Hearings On Registration Suspension Or Revocation Against BioCurex Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of BioCurex Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

BioCurex Inc. will Change its Ticker to BOCX from BOCX.D

Effective January 11, 2013, BioCurex Inc. will change its Pink Sheets LLC stock ticker symbol to BOCX from BOCX.D.

BioCurex Inc. Announces the Resignation of Gladys Chan as Principal Financial and Accounting Officer

On December 31, 2012, Gladys Chan resigned as the BioCurex Inc.'s Principal Financial and Accounting Officer. Ms. Chan's resignation was not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practice.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOCX:US $0.02 USD 0.00

BOCX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOCX.
View Industry Companies

Industry Analysis


Industry Average

Valuation BOCX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCUREX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at